 | • レポートコード：D0804-10795 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、乾癬性関節炎治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。乾癬性関節炎治療薬の種類別市場規模（TNF阻害剤、PDE4阻害剤、インターロイキンブロッカー、その他）、用途別市場規模（軽度乾癬性関節炎、中程度乾癬性関節炎、重度乾癬性関節炎）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Abbvie、Pfizer、Janssen、Amgen、Celgene、Eli-lilly ・地域別グローバル市場分析 2015年-2020年 ・乾癬性関節炎治療薬の北米市場（アメリカ、カナダ、メキシコ） ・乾癬性関節炎治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・乾癬性関節炎治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・乾癬性関節炎治療薬の南米市場（ブラジル、アルゼンチン） ・乾癬性関節炎治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：TNF阻害剤、PDE4阻害剤、インターロイキンブロッカー、その他 ・用途別分析：軽度乾癬性関節炎、中程度乾癬性関節炎、重度乾癬性関節炎 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Psoriatic Arthritis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Psoriatic Arthritis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Psoriatic Arthritis Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Psoriatic Arthritis Drugs market has been segmented into
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
By Application, Psoriatic Arthritis Drugs has been segmented into:
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Psoriatic Arthritis Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Psoriatic Arthritis Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Psoriatic Arthritis Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Psoriatic Arthritis Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Psoriatic Arthritis Drugs Market Share Analysis
Psoriatic Arthritis Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Psoriatic Arthritis Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Psoriatic Arthritis Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Psoriatic Arthritis Drugs are:
Abbvie
Pfizer
Janssen
Amgen
Celgene
Eli-lilly
Among other players domestic and global, Psoriatic Arthritis Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Psoriatic Arthritis Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Psoriatic Arthritis Drugs, with price, sales, revenue and global market share of Psoriatic Arthritis Drugs in 2018 and 2019.
Chapter 3, the Psoriatic Arthritis Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Psoriatic Arthritis Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Psoriatic Arthritis Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Psoriatic Arthritis Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Psoriatic Arthritis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Psoriatic Arthritis Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Psoriatic Arthritis Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Mild Psoriatic Arthritis
1.3.3 Moderate Psoriatic Arthritis
1.3.4 Severe Psoriatic Arthritis
1.4 Overview of Global Psoriatic Arthritis Drugs Market
1.4.1 Global Psoriatic Arthritis Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbvie SWOT Analysis
2.1.4 Abbvie Product and Services
2.1.5 Abbvie Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen
2.3.1 Janssen Details
2.3.2 Janssen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen SWOT Analysis
2.3.4 Janssen Product and Services
2.3.5 Janssen Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Celgene SWOT Analysis
2.5.4 Celgene Product and Services
2.5.5 Celgene Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli-lilly
2.6.1 Eli-lilly Details
2.6.2 Eli-lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli-lilly SWOT Analysis
2.6.4 Eli-lilly Product and Services
2.6.5 Eli-lilly Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Psoriatic Arthritis Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Psoriatic Arthritis Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Psoriatic Arthritis Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Psoriatic Arthritis Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Psoriatic Arthritis Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Psoriatic Arthritis Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Psoriatic Arthritis Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
4.5 South America Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Psoriatic Arthritis Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Psoriatic Arthritis Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Psoriatic Arthritis Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Psoriatic Arthritis Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Psoriatic Arthritis Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Psoriatic Arthritis Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
6.3 UK Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
6.4 France Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Psoriatic Arthritis Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Psoriatic Arthritis Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Psoriatic Arthritis Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
7.5 India Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Psoriatic Arthritis Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Psoriatic Arthritis Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Psoriatic Arthritis Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Psoriatic Arthritis Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Psoriatic Arthritis Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Psoriatic Arthritis Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Psoriatic Arthritis Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Psoriatic Arthritis Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Psoriatic Arthritis Drugs Price by Type (2015-2020)
11 Global Psoriatic Arthritis Drugs Market Segment by Application
11.1 Global Psoriatic Arthritis Drugs Sales Market Share by Application (2015-2020)
11.2 Global Psoriatic Arthritis Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Psoriatic Arthritis Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Psoriatic Arthritis Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Psoriatic Arthritis Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Psoriatic Arthritis Drugs Market Forecast (2021-2025)
12.2.2 Europe Psoriatic Arthritis Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Psoriatic Arthritis Drugs Market Forecast (2021-2025)
12.2.4 South America Psoriatic Arthritis Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Psoriatic Arthritis Drugs Market Forecast (2021-2025)
12.3 Psoriatic Arthritis Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Psoriatic Arthritis Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Psoriatic Arthritis Drugs Market Share Forecast by Type (2021-2025)
12.4 Psoriatic Arthritis Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Psoriatic Arthritis Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Psoriatic Arthritis Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Psoriatic Arthritis Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Psoriatic Arthritis Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Psoriatic Arthritis Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbvie Basic Information, Manufacturing Base and Competitors
Table 8. Abbvie Psoriatic Arthritis Drugs Major Business
Table 9. Abbvie Psoriatic Arthritis Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Abbvie SWOT Analysis
Table 11. Abbvie Psoriatic Arthritis Drugs Product and Services
Table 12. Abbvie Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Psoriatic Arthritis Drugs Major Business
Table 15. Pfizer Psoriatic Arthritis Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Pfizer SWOT Analysis
Table 17. Pfizer Psoriatic Arthritis Drugs Product and Services
Table 18. Pfizer Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Janssen Basic Information, Manufacturing Base and Competitors
Table 20. Janssen Psoriatic Arthritis Drugs Major Business
Table 21. Janssen Psoriatic Arthritis Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Janssen SWOT Analysis
Table 23. Janssen Psoriatic Arthritis Drugs Product and Services
Table 24. Janssen Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Amgen Basic Information, Manufacturing Base and Competitors
Table 26. Amgen Psoriatic Arthritis Drugs Major Business
Table 27. Amgen Psoriatic Arthritis Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Amgen SWOT Analysis
Table 29. Amgen Psoriatic Arthritis Drugs Product and Services
Table 30. Amgen Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Celgene Basic Information, Manufacturing Base and Competitors
Table 32. Celgene Psoriatic Arthritis Drugs Major Business
Table 33. Celgene Psoriatic Arthritis Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Celgene SWOT Analysis
Table 35. Celgene Psoriatic Arthritis Drugs Product and Services
Table 36. Celgene Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Eli-lilly Basic Information, Manufacturing Base and Competitors
Table 38. Eli-lilly Psoriatic Arthritis Drugs Major Business
Table 39. Eli-lilly Psoriatic Arthritis Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Eli-lilly SWOT Analysis
Table 41. Eli-lilly Psoriatic Arthritis Drugs Product and Services
Table 42. Eli-lilly Psoriatic Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Psoriatic Arthritis Drugs Sales by Manufacturer (2018-2019) (K MT)
Table 44. Global Psoriatic Arthritis Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Psoriatic Arthritis Drugs Sales by Regions (2015-2020) (K MT)
Table 46. Global Psoriatic Arthritis Drugs Sales Market Share by Regions (2015-2020)
Table 47. Global Psoriatic Arthritis Drugs Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Psoriatic Arthritis Drugs Sales by Countries (2015-2020) (K MT)
Table 49. North America Psoriatic Arthritis Drugs Sales Market Share by Countries (2015-2020)
Table 50. North America Psoriatic Arthritis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Psoriatic Arthritis Drugs Revenue Market Share by Countries (2015-2020)
Table 52. Europe Psoriatic Arthritis Drugs Sales by Countries (2015-2020) (K MT)
Table 53. Europe Psoriatic Arthritis Drugs Sales Market Share by Countries (2015-2020)
Table 54. Europe Psoriatic Arthritis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Psoriatic Arthritis Drugs Sales by Regions (2015-2020) (K MT)
Table 56. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Psoriatic Arthritis Drugs Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Psoriatic Arthritis Drugs Sales by Countries (2015-2020) (K MT)
Table 59. South America Psoriatic Arthritis Drugs Sales Market Share by Countries (2015-2020)
Table 60. South America Psoriatic Arthritis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Psoriatic Arthritis Drugs Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Psoriatic Arthritis Drugs Sales by Countries (2015-2020) (K MT)
Table 63. Middle East & Africa Psoriatic Arthritis Drugs Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Psoriatic Arthritis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Psoriatic Arthritis Drugs Revenue Market Share by Countries (2015-2020)
Table 66. Global Psoriatic Arthritis Drugs Sales by Type (2015-2020) (K MT)
Table 67. Global Psoriatic Arthritis Drugs Sales Share by Type (2015-2020)
Table 68. Global Psoriatic Arthritis Drugs Revenue by Type (2015-2020) (USD Million)
Table 69. Global Psoriatic Arthritis Drugs Revenue Share by Type (2015-2020)
Table 70. Global Psoriatic Arthritis Drugs Sales by Application (2015-2020) (K MT)
Table 71. Global Psoriatic Arthritis Drugs Sales Share by Application (2015-2020)
Table 72. Global Psoriatic Arthritis Drugs Sales Forecast by Regions (2021-2025) (K MT)
Table 73. Global Psoriatic Arthritis Drugs Market Share Forecast by Regions (2021-2025)
Table 74. Global Psoriatic Arthritis Drugs Sales Forecast by Type (2021-2025) (K MT)
Table 75. Global Psoriatic Arthritis Drugs Market Share Forecast by Type (2021-2025)
Table 76. Global Psoriatic Arthritis Drugs Sales Forecast by Application (2021-2025)
Table 77. Global Psoriatic Arthritis Drugs Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Psoriatic Arthritis Drugs Picture
Figure 2. Global Sales Market Share of Psoriatic Arthritis Drugs by Type in 2019
Figure 3. TNF Inhibitors Picture
Figure 4. PDE4 Inhibitors Picture
Figure 5. Interleukin Blockers Picture
Figure 6. Other Picture
Figure 7. Psoriatic Arthritis Drugs Sales Market Share by Application in 2018
Figure 8. Mild Psoriatic Arthritis Picture
Figure 9. Moderate Psoriatic Arthritis Picture
Figure 10. Severe Psoriatic Arthritis Picture
Figure 11. Global Psoriatic Arthritis Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Psoriatic Arthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Psoriatic Arthritis Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Psoriatic Arthritis Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Psoriatic Arthritis Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Psoriatic Arthritis Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Psoriatic Arthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Psoriatic Arthritis Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Psoriatic Arthritis Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Psoriatic Arthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Psoriatic Arthritis Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Psoriatic Arthritis Drugs Sales Market Share by Countries in 2018
Figure 48. North America Psoriatic Arthritis Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Psoriatic Arthritis Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Psoriatic Arthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Psoriatic Arthritis Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Psoriatic Arthritis Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Psoriatic Arthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Psoriatic Arthritis Drugs Revenue Market Share by Regions 2019
Figure 64. China Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Psoriatic Arthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Psoriatic Arthritis Drugs Sales Market Share by Countries in 2019
Figure 71. South America Psoriatic Arthritis Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Psoriatic Arthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Psoriatic Arthritis Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Psoriatic Arthritis Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Psoriatic Arthritis Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Psoriatic Arthritis Drugs Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Psoriatic Arthritis Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Psoriatic Arthritis Drugs Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Psoriatic Arthritis Drugs Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Psoriatic Arthritis Drugs Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Psoriatic Arthritis Drugs Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Psoriatic Arthritis Drugs Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
関節リウマチ治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Rhematoid Arthritis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rhematoid Arthritis…- 関節リウマチ薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drugs for Rheumatoid Arthritis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 23310 million by 2025, from USD 20320 million in 2019. The Drugs f…
- 新抗ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Novel Antiviral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Novel Antiviral Drugs m…
- 慢性腎臓病（CKD）治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chronic Kidney Disease (CKD) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chronic Ki…
- 直接作用型抗ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Direct-acting Antiviral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Direct-acting A…